According to Travere Therapeutics's latest financial reports the company's current earnings (TTM) are -NZ$0.62 B. In 2023 the company made an earning of -NZ$0.59 B a decrease over its 2022 earnings that were of -NZ$0.48 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.